Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Could ZMapp’s rapid approval set a new precedent?

The rapid use of ZMapp, an experimental treatment for the Ebola virus, raises the question; might the use of experimental drugs be justified in similarly dire circumstances elsewhere? Dominic Nutt, communications director for the Medical Innovation Bill, spoke to Abi Millar about how a proposed new law in the UK stands to encourage a culture change within medicine.

Go Top